FDA Approves First Generics of Lyrica
July 22, 2019 -- On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Brain | Diabetes | Endocrinology | Food and Drug Administration (FDA) | Lyrica | Neurology | Pain | Pain Management | Peripheral Neuropathy | Pharmaceuticals